Launches First Non-Radioactive Test Kit for High Throughput hERG Channel Blockage Screening CARLSBAD, Calif.–Invitrogen Corporation (NASDAQ:IVGN), a leading provider of essential life sciences technologies for research, production and diagnostics, today announced the availability of a proprietary test kit that enables better screening for cardiotoxicity traits of potential drug compounds earlier in the discovery process. The […]
ST. LOUIS, June 19 — Sigma-Aldrich (Nasdaq:SIAL) today announced it has entered into a five-year collaboration to develop optimal cell lines for the production of monoclonal antibodies. Scientists at the University of California, San Francisco will lead the research into antibodies for a variety of cancer targets, autoimmune diseases, stem cell characteristics and commonly neglected […]
Expanded EpiTect portfolio targets growing demand for standardized sample and assay technologies to investigate processes regulating gene function Venlo, The Netherlands – June 18, 2008 – QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced a significant expansion of its EpiTect product portfolio for epigenetics, one of the most dynamic areas in life sciences. With […]
EDMONTON, ALBERTA–(June 18, 2008) – Innovotech Inc. (TSX VENTURE:IOT) is pleased to announce that it has reached agreement with BioSurface Technologies of Bozeman, Montana to market and distribute its patented MBECTM Assay research tool. “Biofilm research and knowledge have seen dramatic growth over the past five years. BioSurface Technologies is the only company that is […]
Invitrogen Corporation (NASDAQ: IVGN) and Applera Corporation today announced that their Boards of Directors have approved a definitive merger agreement, under which Invitrogen will acquire all of the outstanding shares of Applera’s Applied Biosystems Group (NYSE: ABI) in a cash and stock transaction valued at $6.7 billion. This strategic combination will create a global leader […]
BILLERICA, Mass.–Millipore Corporation (NYSE:MIL), a life science leader that provides technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today announced that Jon DiVincenzo has been appointed to succeed Dominique Baly as the President of its Bioscience Division. Mr. DiVincenzo, currently the Vice President, Global Sales and Service, for Millipore’s Bioscience Division, will assume […]
–More than 250,000 Successful DNA Extractions Have Already Been Achieved By Combining the Innovative Products of Both Companies– SOLANA BEACH, Calif. & ALBANY, New Zealand–ZyGEM Corp Ltd., a provider of novel enabling enzymatic tools for life sciences applications, today announced a non-exclusive agreement with Zee Tags, Ltd., a global leader in the provision of livestock […]
AMES, Iowa–BioForce Nanosciences Holdings, Inc. (OTC BB: BFNH – News), a producer of integrated biological and mechanical systems for life science researchers at the micro and nano scales, today announced that it has signed a distribution agreement with NanoAndMore USA, Inc., the North and South American distribution arm of NanoWorld Holding AG. NanoAndMore USA joins […]
– BIOCRATES Life Sciences AG, an Innsbruck, Austria-based metabolomics company, today announced that it has entered into a worldwide co-marketing agreement with Applied Biosystems, a leader in mass spectrometry. Under the terms of the agreement, Biocrates will promote Applied Biosystems’ mass spectrometers for targeted metabolomics and for use in conjunction with their AbsoluteIDQ(TM) Kits. In […]
GenVault Corporation, the leader in dry-state, room temperature biosample management solutions announced on May 29, 2008 that Whatman, now part of GE Healthcare, will become a non-exclusive distributor of GenVault’s GenSolve DNA recovery kits in North America. The GenSolve DNA recovery kit enables FTA(R)1 card users to recovery high quality DNA from their archived samples […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
